RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      Pristimerin Inhibits Inducible Nitric Oxide Synthase Expression Induced by TLR Agonists

      한글로보기

      https://www.riss.kr/link?id=A106109337

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Toll-like receptors (TLRs) are one of the families of pattern recognition receptors (PRR) operating in the innate immunity. TLRs have the ability to recognize relatively conserved microbial components, which are generally referred to as pathogenassoci...

      Toll-like receptors (TLRs) are one of the families of pattern recognition receptors (PRR) operating in the innate immunity.
      TLRs have the ability to recognize relatively conserved microbial components, which are generally referred to as pathogenassociated molecular patterns (PAMPs). The activation of TLRs signaling leads to the activation of NF-κB and the expression of pro-inflammatory gene products such as cytokines and inducible nitric oxide synthase (iNOS). To evaluate the therapeutic potential of pristimerin, which is a naturally occurring triterpenoid compound from Celastraceae plants, iNOS expression induced by MALP-2 (TLR2 and TLR6 agonist), Poly[I:C] (TLR3 agonist), or LPS (TLR4 agonist) were examined. Pristimerin suppressed the iNOS expression induced by MALP-2, Poly[I:C], or LPS. These results suggest that pristimerin can modulate TLRs signaling pathways leading to decreased inflammatory gene expression.

      더보기

      참고문헌 (Reference)

      1 Youn HS, "pecific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex" 175 : 3339-3346, 2005

      2 Sato S, "Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling" 171 : 4304-4310, 2003

      3 Takeda K, "Toll-like receptors in innate immunity" 17 : 1-14, 2005

      4 Akira S, "Toll-like receptor signalling" 4 : 499-511, 2004

      5 Kawai T, "The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors" 11 : 373-384, 2010

      6 윤형선, "The Anti-Inflammatory Effects of Phytochemicals by the Modulation of Innate Immunity" 대한의생명과학회 18 (18): 181-192, 2012

      7 Murakami A, "Targeting NOX, INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals" 121 : 2357-2363, 2007

      8 Youn HS, "Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea" 72 : 850-859, 2006

      9 Hyo Jin Lim, "Suppression of Inducible Nitric Oxide Synthase and Cyclooxygenase-2 Expression by Tussilagone from Farfarae Flos in BV-2 Microglial Cells" 대한약학회 31 (31): 645-652, 2008

      10 Meylan E, "RIP1 is an essential mediator of Tolllike receptor 3-induced NF-kappa B activation" 5 : 503-507, 2004

      1 Youn HS, "pecific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex" 175 : 3339-3346, 2005

      2 Sato S, "Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling" 171 : 4304-4310, 2003

      3 Takeda K, "Toll-like receptors in innate immunity" 17 : 1-14, 2005

      4 Akira S, "Toll-like receptor signalling" 4 : 499-511, 2004

      5 Kawai T, "The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors" 11 : 373-384, 2010

      6 윤형선, "The Anti-Inflammatory Effects of Phytochemicals by the Modulation of Innate Immunity" 대한의생명과학회 18 (18): 181-192, 2012

      7 Murakami A, "Targeting NOX, INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals" 121 : 2357-2363, 2007

      8 Youn HS, "Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea" 72 : 850-859, 2006

      9 Hyo Jin Lim, "Suppression of Inducible Nitric Oxide Synthase and Cyclooxygenase-2 Expression by Tussilagone from Farfarae Flos in BV-2 Microglial Cells" 대한약학회 31 (31): 645-652, 2008

      10 Meylan E, "RIP1 is an essential mediator of Tolllike receptor 3-induced NF-kappa B activation" 5 : 503-507, 2004

      11 Deeb D, "Pristimerin, a quinonemethide triterpenoid, induces apoptosis in pancreatic cancer cells through the inhibition of pro-survival Akt/NFkappaB/ mTOR signaling proteins and anti-apoptotic Bcl-2" 44 : 1707-1715, 2014

      12 Tong L, "Pristimerin, a naturally occurring triterpenoid, protects against autoimmune arthritis by modulating the cellular and soluble immune mediators of inflammation and tissue damage" 155 : 220-230, 2014

      13 Vallance P, "Nitric oxide: therapeutic opportunities" 17 : 1-10, 2003

      14 Knowles RG, "Nitric oxide synthases" 24 : 875-878, 1996

      15 Hultmark D, "Macrophage differentiation marker MyD88 is a member of the Toll/IL-1 receptor family" 199 : 144-146, 1994

      16 Youn HS, "Inhibition of homodimerization of Toll-like receptor 4 by curcumin" 72 : 62-69, 2006

      17 Lechner M, "Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin" 15 : 277-289, 2005

      18 Fitzgerald KA, "IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway" 4 : 491-496, 2003

      19 Ferrero-Miliani L, "Chronic inflammation: importance of NOD2 and NALP3 in interleukin- 1beta generation" 147 : 227-235, 2007

      20 Youn HS, "Auranofin, as an anti-rheumatic gold compound, suppresses LPS-induced homodimerization of TLR4" 350 : 866-871, 2006

      21 Costa PM, "Antiproliferative activity of pristimerin isolated from Maytenus ilicifolia (Celastraceae) in human HL-60 cells" 22 : 854-863, 2008

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2022 평가예정 재인증평가 신청대상 (재인증)
      2019-01-01 평가 등재학술지 유지 (계속평가) KCI등재
      2016-01-01 평가 등재학술지 선정 (계속평가) KCI등재
      2015-12-01 평가 등재후보로 하락 (기타) KCI등재후보
      2015-04-07 학술지명변경 외국어명 : Journal of Experimental and Biomedical Sciences -> Biomedical Science Letters KCI등재
      2011-03-29 학술지명변경 외국어명 : The Journal of Biomedical Laboratory Sciences -> Journal of Experimental and Biomedical Sciences KCI등재
      2011-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2010-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2009-01-01 평가 등재후보 1차 FAIL (등재후보1차) KCI등재후보
      2008-01-01 평가 등재후보학술지 유지 (등재후보1차) KCI등재후보
      2007-01-01 평가 등재후보학술지 유지 (등재후보1차) KCI등재후보
      2006-01-01 평가 등재후보 1차 FAIL (등재후보2차) KCI등재후보
      2005-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2003-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.4 0.4 0.32
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.23 0.19 0.347 0.18
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼